Epidemiology and susceptibility of Serratia marcescens in a large general hospital over an 8-year period

Journal of Hospital Infection

Volumn 45, Issue 1, 2000, Pages 42-46

  Hejazi, A ^a   Aucken, H M ^b   Falkiner, F R ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

Epidemiological typing; Nosocomial infections; Serratia marcescens

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOPHAGE TYPING; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE TRANSMISSION; HOSPITAL INFECTION; INCIDENCE; SEROTYPE; SERRATIA MARCESCENS;

EID: 0034119978     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.1999.0722     Document Type: Article

References (21)

1. Yu VL. Serratia marcescens: historical perspective and clinical review. N Engl J Med. 300:1979;887-893.
2. Coria-Jimenez R, Ortiz-Torres C. Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin. J Epidem Infect. 112:1994;125-131.
3. Hechler, U, Van den Weghe, M, Martin, HH, Frere, JM, Overproduced b-lactamase and the outer-membrane barrier as resistance-factors in Serratia marcescens highly resistant to b-lactamase-stable b-lactam antibiotics, J Gen Microbiol, 135, 1275, 1290.
4. Farmer JJ III, Davis BR, Hickman FW. Detection of Serratia outbreaks in hospital. Lancet. ii:1976;455-459.
5. Coleman D, Falkiner FR, Carr ME. Sim-ultaneous outbreaks of infection due to Serratia marcescens in a general hospital. J Hosp Infect. 5:1984;270-282.
6. Pitt TL. State of the art: typing of Serratia marcescens. J Hosp Infect. 3:1982;4-14.
7. Aucken HM, Wilkinson SG, Pitt TL. Serological classification of Serratia marcescens by lipopolysaccharide (O) and capsular polysaccharide (K) antigens. Microbiology. 144:1998;639-653.
8. Pitt TL, Erdman YJ, Bucher C. The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals. J Hyg (Camb). 4:1980;269-283.
9. Christensen GD, Korones SB, Reed L. Epidemic Serratia marcescens in a neonatal intensive care unit: importance of the gastrointestinal tract as a reservoir. Infect Control. 3:1982;127-133.
10. Lewis DA, Hawkey PM, Watts JA. Infection with netilmicin resistant Serratia marcescens in a special care baby unit. BMJ. 287:1983;1701-1705.
11. Newport M, John JF, Michel YM, Levkoff AH. Endemic Serratia marcescens infection in a neonatal intensive care nursery associated with gastrointestinal colonisation. Ped Infect Dis. 4:1985;160-167.
12. Acar JF. Serratia marcescens infections. Infect Control. 7:1986;273-278.
13. Daschner FD. Graevenitz A, Rubin SJ. The epidemiology of Serratia marcescens. 1980;187-196 CRC Press, Boca Raton.
14. Jones SR, Amon M, Falvey C, Patrick K. Serratia marcescens colonising the gut. Lancet. 1:1978;1105.
15. Grimont PAD, Grimont F. The genus Serratia. Ann Rev Microbiol. 32:1978;221-248.
16. Fracaro M. Serratia marcescens sternal wound infections after cardiac surgery. Amer J Infect Cont. 15:1987;82.
17. Schaberg DR, Alford RH, Anderson R. An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J Infect Dis. 134:1976;181-188.
18. Herra CM, Knowles SJ, Kaufmann ME. An outbreak of an unusual strain of Serratia marcescens in two Dublin hospitals. J Hosp Infect. 38:1998;135-141.
19. Larose P, Picard B, Thibault M. Nosocomial Serratia marcescens individualized by five methodsin a regional hospital. J Hosp Infect. 15:1990;167-172.
20. Bingen EH, Mariani-Kurkdjian P, Lambert-Zechovsky NY. Ribotyping provides efficient differentiation of nosocomial Serratia marcescens isolates in a pediatric hospital. J Clin Microbiol. 30:1992;2088-2091.
21. Hejazi A, Keane CT, Falkiner FR. The use of RAPD-PCR as a typing method forSerratia marcescens. J Med Microbiol. 46:1997;913-919.